ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,841,000 | -32.6% | 64,028 | -16.7% | 0.00% | -33.3% |
Q4 2020 | $4,213,000 | +135.6% | 76,827 | -1.8% | 0.00% | +50.0% |
Q3 2020 | $1,788,000 | +13.4% | 78,227 | +3.8% | 0.00% | 0.0% |
Q2 2020 | $1,577,000 | +66.9% | 75,334 | +11.2% | 0.00% | +100.0% |
Q1 2020 | $945,000 | -15.1% | 67,742 | +38.5% | 0.00% | 0.0% |
Q4 2019 | $1,113,000 | +562.5% | 48,900 | +239.9% | 0.00% | – |
Q3 2019 | $168,000 | -57.6% | 14,386 | -46.2% | 0.00% | -100.0% |
Q4 2018 | $396,000 | -39.9% | 26,752 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $659,000 | – | 26,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |